3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
beta-Thalassemia
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Thalassemia
1
Primary Myelofibrosis
1
Neurofibromatosis 1
1
Neoplasm, Residual
1
Multiple Myeloma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Influenza, Human
1
Chromosome Aberrations
1
Chromosome 7, monosomy
1
Anemia, Sickle Cell
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
ponatinib
4
Methotrexate
4
Cytarabine
4
Cyclophosphamide
4
merphos
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
venetoclax
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cladribine
2
Busulfan
2
prednylidene
1
nilotinib
1
midostaurin
1
gilteritinib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
bosutinib
1
blinatumomab
1
auricularum
1
asciminib
1
Vincristine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
thymoglobulin
×
90 days
×
Clear all
No trials found.